Tag Archives: genomics

Clinical Diagnostic Companies 2013 Financial Metrics and Valuation Models

Diagnostics  Companies-After 2013 Financial Reporting Stocks to Watch: Cepheid (CPHD), Exact Sciences (EXAS) , Orasure (OSUR) Price to Sales (P/S) is the best metric of value as many companies in the sector are not profitable. Molecular diagnostics and genomics are the strongest growth sectors e.g. Cepheid (CPHD), ResponseGenetics (RGDX). Many stocks show a “topping effect” or […]

Comments Off Continue Reading →

A Good Week For Rayno Life Science Stocks: AMRI, CBST, ILMN, RHHBY

Rayno Life Science Movers -Diagnostics Review Next Week Despite some choppiness in biotech trading this week many of our stocks did well. I won’t go into some of the unusual volatility in other small and mid-caps lately  but that is part of the reason for my “bubble” article. There is also a lot of focus […]

Comments Off Continue Reading →

Biotech Bull Market: OK Let’s Just Call It A Bubble

Biotech May Be A Bubble-But What to Do? The blogosphere is trying to temper bullish sentiment with a lot of “bubble “talk even though the cable channels are still pumping biotech.  If you have been around biotech for 25 years especially during the last true bubble -1999 -you should be a little skeptical of the […]

Comments Off Continue Reading →

Rayno Dx and Tools Stocks Up in January: CPHD, ILMN

Molecular Diagnostics and Sequencing Technologies  Are Big Winners in January 2014 But Recent Two Day Sell-Off Has Done Damage To Many Stocks Diagnostic stocks were a sea of red today after a huge January driven by growth expectations from new products and platform molecular technologies. As financial reporting is due for many of these stocks this […]

Comments Off Continue Reading →

Rayno Life Science Movers: AMGN, EXAS, ILMN, PCYC etc.

Update 1/8/13 Blow-Off anticipating J.P.Morgan Conference? Breakthrough: IBB hit new highs above $230 today. Green screen with most large cap and mid caps. ALKS, BIIB among movers. XBI is also up 2%. Rayno Life Science stocks are in the bullish groove as investors move back to growth. As of midday trading the NASDAQ is up […]

Comments Off Continue Reading →

Rayno Life Science Focus Stocks Part II-2013 Performance Diagnostics and Tools

New Products for Molecular and Companion Diagnostics Drive Growth Rayno Life Science Big Winners-ALR, CSII, ILMN,TMO A diversified life science portfolio must include clinical diagnostics and tools stocks because of the synergies between therapy and diagnostics. Breakthroughs in molecular diagnostics for personalized medicine, genetic testing and infectious diseases are driving new product cycles for timely, […]

Comments Off Continue Reading →